Dr. Gregory Kirk, MD, MPH, PhD is the Vice Dean for Research at the Johns Hopkins Bloomberg School of Public Health, and previously served as the Vice Chair for Clinical and Translational Research for the Department of Medicine in the Johns Hopkins School of Medicine. Dr. Kirk graduated from medical school at the University of Oklahoma and completed residency and fellowship training at Johns Hopkins, Georgetown University and the National Institutes of Health. He received his MPH and doctoral degrees in Epidemiology from Johns Hopkins, and now is a Professor in the Departments of Medicine, Epidemiology and Oncology.
Dr. Kirk’s research focuses on understanding and ameliorating the overlapping epidemics of HIV and non-communicable diseases (NCDs) globally. He leads an interdisciplinary group of epidemiologists, clinicians, biostatisticians and behavioral and laboratory scientists involved in a diverse research portfolio in US and international settings (Africa, the Caribbean, the Netherlands). He initiated an NHLBI-funded consortium of Baltimore-based cohorts to longitudinally evaluate chronic pulmonary complications of HIV (SHIELD; Study of HIV Infection in the Etiology of Lung Disease). With >2,500 participants followed with collection of detailed respiratory surveys, biospecimens, and spirometry for 12 years, SHIELD is among the largest and longest running prospective cohorts of lung disease focused on HIV. As Principal Investigator, Dr. Kirk has received >$50 million in NIH grant funding from 6 different NIH institutes. He has contributed to >275 peer-reviewed publications and is an elected Fellow of the Infectious Diseases Society of America, the American College of Epidemiology and American Society of Clinical Investigation. Board-certified in preventive medicine, internal medicine, and infectious diseases, Dr. Kirk maintains certification and continues clinical practice in infectious diseases at Johns Hopkins Hospital and Hopkins Bayview Medical Center.
